Max Planck Society Ends Elsevier Subscription

The move is a show of support for Project DEAL and the open-access movement.

Written byAshley P. Taylor
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: Max Planck Institute for Biophysics
© ISTOCK.COM, OLLO

The Max Planck Society, an enormous German research organization 14,000 scientists strong and comprising multiple research institutes, has ended its subscription to Elsevier journals, the organization announced in a statement this Tuesday (December 18). It did so in support of the German open-access initiative called Project DEAL, after unsuccessful attempts to negotiate an open-access agreement with the publisher. The organization’s digital library will no longer have access to Elsevier’s approximately 2,500 journals, including The Lancet and Cell, once the subscription expires on December 31.

“The system of scholarly publishing today is a relic of the print era, and we want to activate a real paradigm shift in order to finally utilise the opportunities of the digital age,” says Gerard Meijer, director of the Max Planck Society’s (MPS) Fritz Haber Institute and a member of the DEAL negotiating team, in the statement.

Project ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies